Department of Ophthalmology, Faculty of Medicine, Pamukkale University, Kinikli, Turkey.
Ocul Immunol Inflamm. 2021 May 19;29(4):662-665. doi: 10.1080/09273948.2021.1880602. Epub 2021 Apr 1.
: To firstly present management of toxic anterior segment syndrome (TASS) and possible postoperative endophthalmitis (POE) after implantation of a new hydrophilic-acrylic posterior chamber (PC) phakic intraocular lens (pIOL) in a case with undeclared history of COVID-19. A 21-year-old male without known disease represented severe anterior chamber inflammation (hypopyon), poor vision and corneal edema without vitreous involvement (TASS) at 24-hours after PC-pIOL implantation for unilateral high myopia (amblyopic). Preoperative best-corrected visual acuity (BCVA) was 0.2 OS (-13 diopters). At 56-hours, vitreous was involved with visual loss indicating POE. The patient confessed that he had COVID-19 1-month ago. COVID-19 immunoglobulin M/G tests were positive, while other markers were negative. Intracameral/intravitreal antibiotics were applied. BCVA was 0.15 without hypopyon at 24-hours. Cultures were negative. Final BCVA was 0.6 with normal examination. TASS/POE etiology could not be demonstrated in this case, whereas COVID-19-related proinflammatory systemic background could have effect on triggering/aggravating this scenario.].
: 首先介绍了在一名未公开 COVID-19 病史的患者中植入新型亲水性丙烯酸后房型房角固定型人工晶状体(PC-pIOL)后,有毒眼前节综合征(TASS)的管理以及可能发生的术后眼内炎(POE)。一名 21 岁男性因单侧高度近视(弱视)行 PC-pIOL 植入术后 24 小时出现严重前房炎症(前房积脓)、视力差和角膜水肿但无玻璃体受累(TASS)。术前最佳矫正视力(BCVA)为 0.2 OS(-13 屈光度)。术后 56 小时,玻璃体受累导致视力丧失,提示 POE。患者承认他在 1 个月前感染了 COVID-19。COVID-19 免疫球蛋白 M/G 检测呈阳性,而其他标志物检测为阴性。眼内/玻璃体腔内应用抗生素。术后 24 小时前房积脓消失,BCVA 为 0.15。培养物为阴性。最终 BCVA 为 0.6,检查正常。在这种情况下,无法确定 TASS/POE 的病因,而 COVID-19 相关的促炎全身背景可能对触发/加重这种情况有影响。